The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2011-12-01
|
| Collection: | Oncology Reviews |
| Sujets: | |
| Accès en ligne: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|